Core Viewpoint - The company Gan Zhicao is preparing for an IPO, having established itself as a leader in China's online traditional Chinese medicine (TCM) sector, but faces challenges with high growth and low profitability [1][5]. Group 1: Company Overview - Gan Zhicao was founded in 2015, inspired by a moment when a co-founder had to write a prescription on a napkin, leading to the idea of integrating TCM with the internet [2]. - The company holds a 4.9% market share in the online TCM comprehensive service market and a 16.7% share in the online TCM diagnosis service segment, significantly outpacing its competitors [2][4]. - The business model leverages digital tools to streamline the entire process from diagnosis to medication and daily health maintenance, serving both patients and small TCM clinics [3]. Group 2: Financial Performance - Revenue is projected to grow from 603 million yuan in 2023 to 690 million yuan in 2024, with 555 million yuan achieved in the first nine months of 2025 [4]. - Despite revenue growth, the company reported a net loss of 123.5 million yuan in the first nine months of 2025, primarily due to increased sales and distribution expenses [6][7]. - The gross profit margin for online TCM diagnosis services is between 22% and 24%, while offline services have a lower margin of 6.7% to 13.4% [6]. Group 3: Market Context - The online TCM comprehensive service market in China has expanded dramatically from 2.7 billion yuan in 2019 to an estimated 13 billion yuan in 2024 [5]. - The company's revenue structure is diversifying, with the share of online TCM diagnosis services decreasing from 85.3% to 70.1%, while SaaS and consumer health products are gaining ground [6]. Group 4: Capital and Governance - Gan Zhicao has seen a significant increase in valuation, rising from under 7 million yuan in early 2023 to over 1.6 billion yuan, a 240-fold increase [8][9]. - The company has engaged in multiple capital operations, including share transfers and investments from various institutions, raising concerns about governance and related party transactions [9][10]. - The company has not yet secured professional medical liability insurance for its online TCM services, which poses potential risks [7].